Respiri Limited has expanded its senior executive team, with the appointment of Theo Antonopoulos as Chief Commercial Officer effective 7 June 2021. His frame of reference has been shaped over +20 years working in roles of increasing responsibility, predominantly within the Pharmaceutical industry and more recently as Executive Head of Marketing and Sales at MedAdvisor. In this role, he led the Commercial arm, overseeing its growth from an Australian start-up with revenues.